ARCHIVES

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

Rosemond Asks Ban On High Tar, Nicotine Cigarettes

November 28, 1975

In Brief: san Antonio’s ICRC Gets a New Name, SACI; Blum Is deputy Oncology Director At Kaplan

May 14, 1993

New NCI Director Plans Greater Support For Translational Research, Collaboration.

March 1, 2002

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

November 14, 2014

MD Anderson Survey Shows Faculty Dissatisfaction with Top Leaders

May 23, 2014

Nevins Retracts Key Paper By Duke Group, Raising Question Of Harm To Patients

October 29, 2010